You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

34 Results
Guidelines and Advice
Status: Archived
ID: 5-6c
Nov 2000
Guidelines and Advice
Status: Current
ID: 3-14
Version: 3
Updated
Jun 2025
Guidelines and Advice
Status: Current
ID: GL MOTAC-4
Version: 3
Updated
Jun 2025
Drug
Other Name(s): Arimidex®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Drug
Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Drug
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Drug
Other Name(s): Adcetris®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Drug
Other Name(s): Tafinlar®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Drug
Other Name(s): Mekinist®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Drug
Other Name(s): Rydapt®
Quick Link(s): Drug Monograph, Patient Info Sheet
Jun 2025
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue, 
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
dacarbazine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
riTUXimab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025

Pages